awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55429844-3D9CE38F-EDB1-4D4F-8074-AFA20C68E036
Q55429844-3D9CE38F-EDB1-4D4F-8074-AFA20C68E036
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-3D9CE38F-EDB1-4D4F-8074-AFA20C68E036
Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.
P2860
Q55429844-3D9CE38F-EDB1-4D4F-8074-AFA20C68E036
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-3D9CE38F-EDB1-4D4F-8074-AFA20C68E036
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f4495b49004ebd2816f77410e60e0c407c516cb3
P2860
Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.